Annexon Stock Statistic Functions Linear Regression Intercept

ANNX Stock  USD 5.45  0.01  0.18%   
Use the statistic functions workspace to apply Linear Regression Intercept function and other studies to Annexon. It emphasizes statistical functions describing dispersion and variability while keeping volatility, risk, and performance context in view.Enter Time Period to run this model.

Function
Time Period
Execute Function
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Linear Regression Intercept is the expected mean value of Annexon price seriese where values of its benchmark or peer price series are zero.

Annexon Technical Analysis Modules

Most technical analysis of Annexon help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Annexon from various momentum indicators to cycle indicators. When you analyze Annexon charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company was incorporated in 2011 and is headquartered in Brisbane, California. Annexon operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 75 people. The stock overview for Annexon summarizes business drivers, financial profile, and market behavior. The company is positioned within Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Current metrics include P/B of 5.61. Annexon has a market cap of 898.81 M, ROE of -83.99%.

Methodology

Unless otherwise specified, financial data for Annexon is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Annexon (USA Stocks:ANNX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We use public filings and market reference sources with disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO) as reference inputs. Data may be normalized and can be delayed. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Annexon is covered by 9 analysts. 4 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include J.P. Morgan, Guggenheim Securities, Bank of America Securities, Oppenheimer & Co., Evercore ISI, Goldman Sachs, Deutsche Bank, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Raphi Shpitalnik - Junior Member of Macroaxis Editorial Board

Become your own money manager

Tracking Annexon inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Money Managers Now

   

Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Picks Idea
Macroaxis Picks
Invested few shares
FinTech Idea
FinTech
Invested over 20 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Momentum Idea
Momentum
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Corona Opportunity Idea
Corona Opportunity
Invested few shares
Impulse Idea
Impulse
Invested over 200 shares
Advertising Idea
Advertising
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Data Storage Idea
Data Storage
Invested few shares

More Resources for Annexon Stock Analysis

A comprehensive view of Annexon starts with financial statements and ratio context. Financial ratios provide context for profitability, efficiency, and growth trends. Outlined below are key reports that provide context for Annexon Stock:
Annexon has a market cap of 898.81 M, ROE of -83.99%. See Trending Equities for portfolio-level analysis. This suggests a position in Annexon within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
For a detailed overview of how to trade Annexon Stock, see our How to Trade Annexon Stock guide.
Analysis related to Annexon should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
 Earnings Share
-1.41
 Return On Assets
-0.45
 Return On Equity
-0.84
Understanding Annexon includes distinguishing between market value and book value, where book value reflects Annexon's accounting equity. Annexon's market capitalization is 898.81 M. With a P/B ratio of 5.61, the market values Annexon well above its book equity. Enterprise value stands at 737.02 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
The concept of value for Annexon differs from its quoted price, since each reflects a different lens. For Annexon, key inputs include a P/B ratio of 5.61, and ROE of -83.99%. Trading price represents the transaction level agreed by market participants.